1
|
Wollmer E, Karkossa F, Freerks L, Hetberg AE, Neal G, Porter J, Whitaker MJ, Margetson D, Klein S. A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone Drug Product within Common Pediatric Dosing Vehicles. Pharm Res 2020; 37:203. [PMID: 32968894 PMCID: PMC7511475 DOI: 10.1007/s11095-020-02912-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Accepted: 08/17/2020] [Indexed: 01/01/2023]
Abstract
Purpose The objective of the present work was to screen whether a novel pediatric hydrocortisone granule formulation can be co-administered with common food matrices and liquids. Methods Pediatric hydrocortisone granules were studied using a biopredictive in vitro approach. Experiments included an in situ chemical compatibility study of active ingredient and drug product with liquid dosing vehicles and soft foods commonly ingested by infants, pre-school- and school children. Drug solubility and stability experiments in the different vehicle types and, drug release/dissolution experiments mimicking age-related pediatric gastric conditions after administering the hydrocortisone granules together with the dosing vehicles and after different exposure/mixing times were performed. Results In the simulated dosing scenarios applied in dissolution experiments, in vitro dissolution in gastric conditions was rapid and complete. Results of the chemical compatibility/stability studies indicated that mixing with the different dosing vehicles studied should not be an issue regarding drug degradation products. Conclusions A novel in vitro approach ensuring a proper risk assessment of the use of dosing vehicles in the administration of pediatric dosage forms was established and applied to a novel pediatric hydrocortisone drug product. The studied dosing vehicles were shown to not alter performance of the drug product and are thus considered suitable for administration with hydrocortisone granules. Graphical abstract ![]()
Electronic supplementary material The online version of this article (10.1007/s11095-020-02912-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Erik Wollmer
- Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany
| | - Frank Karkossa
- Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany
| | - Lisa Freerks
- Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany
| | - Anna-Elena Hetberg
- Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany
| | - Greg Neal
- Diurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK
| | - John Porter
- Diurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK
| | - Martin J Whitaker
- Diurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK
| | - Daniel Margetson
- Diurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK
| | - Sandra Klein
- Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany.
| |
Collapse
|